Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

We evalueted a systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) with the aim to explored their prognostic value in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. 56 advanced HCC patients receiving sorafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardini, Andrea Casadei, Scarpi, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Santini, Daniele, de Stefano, Giorgio, Marisi, Giorgia, Negri, Francesca V., Foschi, Francesco Giuseppe, Valgiusti, Martina, Ercolani, Giorgio, Frassineti, Giovanni Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341863/
https://www.ncbi.nlm.nih.gov/pubmed/27613839
http://dx.doi.org/10.18632/oncotarget.11565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341863/
https://www.ncbi.nlm.nih.gov/pubmed/27613839
http://dx.doi.org/10.18632/oncotarget.11565

Ejemplares similares